← Leaderboards
Sandra Reichstetter
Pharmain Corporation
$723,989
Attributed
$971,968
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $300K · FY2009–13$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$971,968 · 2
By mechanism
R43$971,968 · 2
Top collaborators
- Elijah M. Bolotin2 shared
- Gerardo M. Castillo2 shared
Most similar at Pharmain Corporation
Same institution · by research overlap
- Elijah M. Bolotin$3,712,057
- Gerardo M. Castillo$15,494,100
- Elijah M Bolotin$1,915,481
Others in their field
Top investigators on “Immune System Diseases”
- Lawrence Corey · Fred Hutchinson Cancer Center$530,238,525
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$314,842,858
- Judith S. Currier · University Of California Los Angeles$247,454,340
- Peter B. Gilbert · Fred Hutchinson Cancer Center$211,182,168
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$175,579,129
- Barton F Haynes · Duke University$117,528,869
Research focus
Immune System DiseasesLeadDoseHypersensitivityInflammatoryKidneyChronicCytokineDrug Delivery SystemsHalf-LifeAnimal ModelBinding (Molecular Function)Insulin-Dependent Diabetes MellitusIn VivoBiological AvailabilityAdverse EffectsBloodCopolymerBlood PressureDropsDrug FormulationsExcretory FunctionBaseMouse Model
Grant awards (4)
Vasoactive intestinal peptide for the treatment of psoriasis$145,203
R43 · FY2013 · AI · contact PI
Vasoactive intestinal peptide for the treatment of psoriasis$226,765
R43 · FY2012 · AI · contact PI
Long-acting VIP formulations for the treatment of chronic inflammatory diseases$300,000
R43 · FY2010 · AI · contact PI
Long-acting VIP formulations for the treatment of chronic inflammatory diseases$300,000
R43 · FY2009 · AI · contact PI